120 related articles for article (PubMed ID: 7416810)
1. Tumour markers with unknown functions in gynaecological neoplasia.
Price MR; McLaughlin PJ; Robins RA; Baldwin RW; Vasey D; Symonds EM
Arch Gynecol; 1980; 229(4):325-31. PubMed ID: 7416810
[TBL] [Abstract][Full Text] [Related]
2. [Circulating T cells in patients with breast or genital cancers in the pre-therapeutic phase].
Strache RR; Büttner HH; Kunze M; Röpcke G
Zentralbl Gynakol; 1989; 111(12):816-23. PubMed ID: 2788342
[TBL] [Abstract][Full Text] [Related]
3. Levels of circulating immune complexes in patients with ovarian cancer.
Clarke AG; Vasey DP; Symonds EM; Faratian B; McLaughlin PJ; Price MR; Baldwin RW
Br J Obstet Gynaecol; 1982 Mar; 89(3):231-7. PubMed ID: 7066260
[TBL] [Abstract][Full Text] [Related]
4. [Carcinoembryonic antigen in gynecological oncology].
Stiglmayer R
Fortschr Med; 1978 Oct; 96(37):1843-5. PubMed ID: 700565
[TBL] [Abstract][Full Text] [Related]
5. A sequential study of humoral factors in ovarian neoplasms.
Gupta SC; Agarwal J; Singh PA; Mehdiratta NK; Keswani NK
Indian J Pathol Microbiol; 1994 Jul; 37(3):319-26. PubMed ID: 7814065
[TBL] [Abstract][Full Text] [Related]
6. An investigation of NCRC11 immunoreactivity in normal and neoplastic epithelia of the female genital tract and ovary.
Hitchcock A; Ellis IO; Bell J; Robins A
Histopathology; 1989 Aug; 15(2):187-94. PubMed ID: 2777219
[TBL] [Abstract][Full Text] [Related]
7. Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients.
Gourevitch MM; von Mensdorff-Pouilly S; Litvinov SV; Kenemans P; van Kamp GJ; Verstraeten AA; Hilgers J
Br J Cancer; 1995 Oct; 72(4):934-8. PubMed ID: 7547243
[TBL] [Abstract][Full Text] [Related]
8. Carcinoembryonic antigen in cancer of the female reproductive system: its detection in serum by a microradioimmunoassay.
Khoo SK; Mackay EV
Aust N Z J Obstet Gynaecol; 1973 May; 13(2):107-13. PubMed ID: 4518714
[No Abstract] [Full Text] [Related]
9. Serum levels and biochemical characteristics of human ovarian carcinoma-associated antigen defined by murine monoclonal antibody, CF511.
Ohkawa K; Tsukada Y; Murae M; Kimura E; Takada K; Abe T; Terashima Y; Mitani K
Br J Cancer; 1989 Dec; 60(6):953-60. PubMed ID: 2605105
[TBL] [Abstract][Full Text] [Related]
10. [Carcino-embryogenic antigen (CEA) in patients with genital tumors (author's transl)].
Anger H; Gleissenberger U
Geburtshilfe Frauenheilkd; 1977 Jul; 37(7):604-8. PubMed ID: 885332
[TBL] [Abstract][Full Text] [Related]
11. Immune status in patients cured of breast and gynaecological cancer.
Haim N; Rudik L; Samuelly B; Mekori T; Robinson E
Clin Oncol; 1981 Jun; 7(2):141-7. PubMed ID: 7249436
[No Abstract] [Full Text] [Related]
12. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.
Sekine H; Hayes DF; Ohno T; Keefe KA; Schaetzl E; Bast RC; Knapp R; Kufe DW
J Clin Oncol; 1985 Oct; 3(10):1355-63. PubMed ID: 2413181
[TBL] [Abstract][Full Text] [Related]
13. CA-125 in gynecological malignancies.
Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):713-7. PubMed ID: 2443359
[TBL] [Abstract][Full Text] [Related]
14. Urine excretion of tumor-associated antigens by patients with gynecologic neoplasms.
Rote NS; Smith WG; Johnson GH
Gynecol Oncol; 1980 Jun; 9(3):370-5. PubMed ID: 6991377
[No Abstract] [Full Text] [Related]
15. Analysis of sera from ovarian cancer patients for immune complexes.
Witkin SS; Bongiovanni AM; Armbruster T; Birnbaum S; Caputo T
J Clin Lab Immunol; 1984 Jun; 14(2):65-8. PubMed ID: 6748047
[TBL] [Abstract][Full Text] [Related]
16. Clinical use of gynaecologic tumour markers.
Halila H; Alfthan H; Stenman UH
Ann Chir Gynaecol; 1989; 78(1):65-70. PubMed ID: 2547331
[TBL] [Abstract][Full Text] [Related]
17. New trends in the surgery of gynaecological tumours.
Szánthó A; Papp Z
Acta Med Hung; 1994; 50(3-4):195-203. PubMed ID: 8587833
[TBL] [Abstract][Full Text] [Related]
18. Expression of MHC products and leucocyte differentiation antigens in gynaecological neoplasms: an immunohistological analysis of the tumour cells and infiltrating leucocytes.
Ferguson A; Moore M; Fox H
Br J Cancer; 1985 Oct; 52(4):551-63. PubMed ID: 2415145
[TBL] [Abstract][Full Text] [Related]
19. [Tumor markers and their significance in gynecologic oncology].
Melchert F; Kreienberg R
Gynakologe; 1980 Jun; 13(2):74-88. PubMed ID: 6299910
[No Abstract] [Full Text] [Related]
20. A review of tumor antigens in gynecologic malignancies.
Gall SA
J Reprod Med; 1975 Jan; 14(1):12-6. PubMed ID: 162963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
